You are here » Home » Markets » Stocks » Announcements

ANNOUNCEMENTS

Announcement for "Aurobindo Pharma Ltd"

Aurobindo Pharma Ltd Updates

  • 19/04/2017
  • |
  • bse

Aurobindo Pharma Ltd Updates

  • 19/04/2017
  • |
  • bse

Aurobindo Pharma Ltd Clarification sought from Aurobindo Pharma Ltd

  • 19/04/2017
  • |
  • bse

Aurobindo Pharma Ltd Compliance Certificate For The Period Ended 31.03.2017

  • 10/04/2017
  • |
  • bse

Aurobindo Pharma Ltd Statement Of Investor Complaints For The Quarter Ended 31.03.2017

  • 10/04/2017
  • |
  • bse

Aurobindo Pharma Ltd Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations 2011

  • 06/04/2017
  • |
  • bse

Aurobindo Pharma Ltd Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011

  • 05/04/2017
  • |
  • bse

Aurobindo Pharma Ltd Allotment Of 15000 Equity Shares Of Re.1/- Each Under ESOP

  • 30/03/2017
  • |
  • bse

Aurobindo Pharma Ltd Press Release

  • 30/03/2017
  • |
  • bse

Aurobindo Pharma Ltd Updates

  • 28/03/2017
  • |
  • bse

Aurobindo Pharma Ltd Press Release

  • 27/03/2017
  • |
  • bse

Aurobindo Pharma Ltd Updates

  • 24/03/2017
  • |
  • bse

Aurobindo Pharma Ltd Updates

  • 20/03/2017
  • |
  • bse

Aurobindo Pharma Ltd Allotted 697823 Equity Shares Of Re.1/- Each Under ESOP Scheme Of The Company

  • 10/03/2017
  • |
  • bse

Aurobindo Pharma Ltd Allotment of Shares under ESOP

  • 09/03/2017
  • |
  • bse

Aurobindo Pharma Ltd Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011

  • 06/03/2017
  • |
  • bse

Aurobindo Pharma Ltd Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011

  • 06/03/2017
  • |
  • bse

Aurobindo Pharma Ltd Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations 2011

  • 28/02/2017
  • |
  • bse

Aurobindo Pharma Ltd Transcript of earnings call

  • 23/02/2017
  • |
  • bse

Aurobindo Pharma Ltd Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations 2011

  • 23/02/2017
  • |
  • bse